shibazaki masahiko

Research theme for competitive and other funds (10)：

2021 - 2023 ヘムオキシゲナーゼを分子標的とした悪性黒色腫の浸潤転移抑制方法の確立
2018 - 2021 The study for the role of NFE2L2 on cell invasion in malignant melanomas.
2017 - 2020 Expression of hyaladherin induced by inactivation of Hippo pathway in malignant mesothelioma
2013 - 2016 Effect of RhoGDI2 expression on progression of colon cancer
2012 - 2015 Involvement of lincRNA in carcinogenesis

Show all

Papers (39)：

Hirofumi Kamada, Shinji Yasuhira, Masahiko Shibazaki, Hiroo Amano, Chihaya Maesawa. DUSP4 Inactivation Leads to Reduced Extracellular Signal-Regulated Kinase Activity through Upregulation of DUSP6 in Melanoma Cells. Journal of Investigative Dermatology. 2022. 142. 9. 2499-2507.e6
Zhiqian Yu, Masahiro Shibazaki, Hirotada Otsuka, Haruhiko Takada, Masanori Nakamura, Yasuo Endo. Dynamics of Platelet Behaviors as Defenders and Guardians: Accumulations in Liver, Lung, and Spleen in Mice. Biological and Pharmaceutical Bulletin. 2019. 42. 8. 1253-1267
Masao Nishiya, Shinji Yasuhira, Masahiko Shibazaki, Hiroki Oikawa, Tomoyuki Masuda, Chihaya Maesawa. Fluvastatin exerts an antitumor effect in vemurafenib-resistant melanoma cells. Anti-Cancer Drugs. 2019. 30. 5. 451-457
Eri Saeki, Shinji Yasuhira, Masahiko Shibazaki, Hiroshi Tada, Minoru Doita, Tomoyuki Masuda, Chihaya Maesawa. Involvement of C-terminal truncation mutation of kinesin-5 in resistance to kinesin-5 inhibitor. PLOS ONE. 2018. 13. 12. e0209296-e0209296
Nobuyuki Arakawa, Ayaka Okubo, Shinji Yasuhira, Kazuhiro Takahashi, Hiroo Amano, Toshihide Akasaka, Tomoyuki Masuda, Masahiko Shibazaki, Chihaya Maesawa. Carnosic acid, an inducer of NAD(P)H quinone oxidoreductase 1, enhances the cytotoxicity of β-lapachone in melanoma cell lines. Oncology Letters. 2017

ｍore...

MISC (2)：

Sho Kakizawa, Masahiko Shibazaki, Nozomu Mori, Hiroshi Takeshima. Protein Oxidation Inhibits Nitric Oxide-Mediated Signaling Pathway Essential for Synaptic Plasticity. BIOPHYSICAL JOURNAL. 2011. 100. 3. 89-89
Naoko Izutsu, Chihaya Maesawa, Masahiko Shibazaki, Hiroki Oikawa, Tadahiro Shoji, Toru Sugiyama, Tomoyuk Masuda. Epigenetic modification is involved in aberrant expression of class III beta-tubulin, TUBB3, in ovarian cancer cells. INTERNATIONAL JOURNAL OF ONCOLOGY. 2008. 32. 6. 1227-1235

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page